Patents by Inventor Thierry Olivry

Thierry Olivry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF ALLERGIC DISEASES WITH CHIMERIC PROTEIN
    Publication number: 20220220223
    Abstract: The present invention provides a chimeric protein comprising: a) a single chain variable fragment (scFv); b) a linker peptide; and c) an amino acid sequence comprising an IgE high affinity receptor alpha chain, and methods of use thereof.
    Type: Application
    Filed: April 1, 2022
    Publication date: July 14, 2022
    Inventors: Bruce Hammerberg, Sitka Eguiluz-Hernandez, Thierry Olivry
  • Treatment of allergic diseases with chimeric protein
    Patent number: 11352443
    Abstract: The present invention provides a chimeric protein comprising: a) a single chain variable fragment (scFv) that binds to a mammalian IgE at an epitope within the amino acid sequence VDGQKATNIFPYTAPGTK (SEQ ID NO:1) of canine IgE or at an epitope within the corresponding amino acid sequence of a different mammalian species; b) a linker peptide; and c) an amino acid sequence comprising an IgE high affinity receptor alpha chain, and methods of use thereof.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: June 7, 2022
    Assignee: North Carolina State University
    Inventors: Bruce Hammerberg, Sitka Eguiluz-Hernandez, Thierry Olivry
  • METHODS AND COMPOSITIONS FOR ALLERGIC DISORDERS
    Publication number: 20210009678
    Abstract: The present invention relates to methods and compositions for treating, reducing, delaying, and/or preventing flares (e.g., recurrences, relapses) of allergic disorders with a biologic agent.
    Type: Application
    Filed: March 22, 2019
    Publication date: January 14, 2021
    Inventors: Bruce Hammerberg, Thierry Olivry
  • TREATMENT OF ALLERGIC DISEASES WITH CHIMERIC PROTEIN
    Publication number: 20180230236
    Abstract: The present invention provides a chimeric protein comprising: a) a single chain variable fragment (scFv) that binds to a mammalian IgE at an epitope within the amino acid sequence VDGQKATNIFPYTAPGTK (SEQ ID NO:1) of canine IgE or at an epitope within the corresponding amino acid sequence of a different mammalian species; b) a linker peptide; and c) an amino acid sequence comprising an IgE high affinity receptor alpha chain, and methods of use thereof.
    Type: Application
    Filed: March 23, 2018
    Publication date: August 16, 2018
    Inventors: Bruce Hammerberg, Sitka Eguiluz-Hernandez, Thierry Olivry